Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005627
Status:
COMPLETED
Last Update Posted:
2013-07-18
First Post:
2000-05-02
Brief Title:
Estramustine Docetaxel and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Sponsor:
Dana-Farber Cancer Institute
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
DFCI-98238
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dana-Farber Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |